Why the study?
Coronary artery disease necessitates assessing plaque formation risk using atherogenic indices, but the relationship between the triglyceride-total cholesterol-body weight index and stenosis severity remains unclear.
Do atherogenic indices and TCBI correlate with the severity of coronary artery stenosis in patients undergoing angiography?
Do atherogenic indices and TCBI correlate with the severity of coronary artery stenosis in patients undergoing angiography?
Atherogenic indices such as AIP, CRI-I, and CRI-II in women, and AC in men, are significantly associated with the severity of coronary artery stenosis, whereas TCBI is not.
Should not yet change practice for stenosis assessment; leaves open sex-specific atherogenic index utility and TCBI's anatomic role.
OBJECTIVES: Coronary artery disease, caused by atherosclerosis, necessitates assessing plaque formation risk using indices like the atherogenic index of plasma (AIP), Castelli's risk indexes (CRI-I and CRI-II), the atherogenic coefficient (AC), and the triglyceride-total cholesterol-body weight index (TCBI). Although TCBI primarily assesses mortality risk, its relationship with stenosis severity is unclear. Utilizing data from a prior study, a case-control analysis was conducted on 1,187 subjects, which included 781 patients who underwent coronary angiography and 406 healthy controls. The indices were compared across varying degrees of arterial blockages. RESULTS: AIP significantly correlated with stenosis severity in women, increasing the risk of three-vessel stenosis by 2.5 times. AC raised the risk of single-vessel stenosis in men by 2.7 times. CRI-I and CRI-II showed a positive relationship with arterial stenosis in women, with CRI-I increasing the risk of two and three-vessel blockages by 21.9% and 22.4%, respectively. A one-unit increase in CRI-II raised the risk by 33.1% for two arteries and 25.3% for three. In conclusion, AIP, CRI-I, and CRI-II in women, along with AC in men, correlated with arterial stenosis severity, while TCBI did not. Further research is needed to determine which index is most effective in predicting CAD risk.
No takes yet. Share an insight, caveat, or question.
Imannezhad et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: